A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS

Marianna Halasi1, Renáta Váraljai2, Elizaveta Benevolenskaya2

  • 1From the Departments of Medicine and.

Insights

Proteasome inhibitors suppress the oncogenic FOXM1 protein by inducing heat shock protein 70 (HSP70). This novel mechanism reveals HSP70 as a key player in targeting FOXM1 for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The transcription factor FOXM1 is frequently overexpressed in human cancers, making it a promising target for anticancer therapies.
  • Proteasome inhibitors were previously identified as the first class of drugs capable of targeting FOXM1 in cancer cells.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which proteasome inhibitors suppress FOXM1.
  • To investigate the role of heat shock proteins (HSPs) in FOXM1 regulation under proteotoxic stress.

Main Methods:

  • Treatment of cancer cells with proteasome inhibitors, HSP90 inhibitor PF-4942847, and heat shock.
  • Analysis of FOXM1 and HSP70 expression levels and interactions.
  • Assessment of HSP70 binding to FOXM1 and its effect on FOXM1 DNA-binding ability and transcriptional activity.
  • Evaluation of cancer cell sensitivity to apoptosis induction.

Main Results:

  • Both proteasome inhibitors and HSP90 inhibition/heat shock lead to the induction of the molecular chaperone HSP70.
  • HSP70 binds to FOXM1 following proteotoxic stress, inhibiting its DNA-binding ability and transcriptional autoregulation.
  • This inhibition results in decreased FOXM1 protein expression.
  • Suppression of HSP70 leads to increased FOXM1 expression, while simultaneous inhibition of FOXM1 and HSP70 enhances cancer cell sensitivity to apoptosis.

Conclusions:

  • A novel mechanism for FOXM1 suppression by proteasome inhibitors involves the induction of HSP70.
  • HSP70 directly inhibits FOXM1 activity and protein levels, offering a new therapeutic strategy.
  • Targeting both FOXM1 and HSP70 may enhance the efficacy of anticancer drugs by increasing apoptosis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
20.8K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

15.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K